Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV) is the most common cause of respiratory tract infection in infants and children and shows increasing trend among elderly people worldwide. In many developing country settings, population and household structures have gone through some significant changes in the past...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Mahikul, W, White, L, Poovorawan, K, Soonthornworasiri, N, Sukontamarn, P, Chanthavilay, P, F Medley, G, Pan-Ngum, W
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Public Library of Science 2019

Παρόμοια τεκμήρια

Modeling household dynamics on Respiratory Syncytial Virus (RSV).
ανά: Wiriya Mahikul, κ.ά.
Έκδοση: (2019-01-01)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis
ανά: Mahikul, W, κ.ά.
Έκδοση: (2019)

A population dynamic model to assess the diabetes screening and reporting programs and project the burden of undiagnosed diabetes in Thailand
ανά: Mahikul, W, κ.ά.
Έκδοση: (2019)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis.
ανά: Wiriya Mahikul, κ.ά.
Έκδοση: (2019-05-01)

Pathobiology of Respiratory Syncytial Virus (RSV)
ανά: Ralph A. Tripp, κ.ά.
Έκδοση: (2020-07-01)

Respiratory Syncytial Virus (RSV) Update
ανά: Leonard R. Krilov, κ.ά.
Έκδοση: (2022-09-01)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
ανά: Kinyanjui, T, κ.ά.
Έκδοση: (2020)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England and Wales and Finland: seasonality and cross-protection.
ανά: White, L, κ.ά.
Έκδοση: (2005)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
ανά: Jackelyn Murray, κ.ά.
Έκδοση: (2022-04-01)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection
ανά: White, L, κ.ά.
Έκδοση: (2005)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
ανά: Dvir Gatt, κ.ά.
Έκδοση: (2023-01-01)

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
ανά: Pan-Ngum, W, κ.ά.
Έκδοση: (2016)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
ανά: Timothy Kinyanjui, κ.ά.
Έκδοση: (2020-04-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
ανά: Gengxin Zhang, κ.ά.
Έκδοση: (2024-10-01)

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.
ανά: Shira Hirsh, κ.ά.
Έκδοση: (2014-01-01)

Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination
ανά: Mohamad El Labban, κ.ά.
Έκδοση: (2024-06-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
ανά: Mark R. Ackermann, κ.ά.
Έκδοση: (2012-10-01)

Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
ανά: Samuel PC Brand, κ.ά.
Έκδοση: (2020-03-01)

Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.
ανά: Rachel J Derscheid, κ.ά.
Έκδοση: (2013-01-01)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
ανά: Antepowicz, A, κ.ά.
Έκδοση: (2018)

Monoterpene-Containing Substituted Coumarins as Inhibitors of Respiratory Syncytial Virus (RSV) Replication
ανά: Tatyana M. Khomenko, κ.ά.
Έκδοση: (2021-12-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
ανά: Selir M. Straliotto, κ.ά.
Έκδοση: (1994-03-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
ανά: Selir M. Straliotto, κ.ά.
Έκδοση: (1994-03-01)

Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
ανά: Envera Lekic, κ.ά.
Έκδοση: (2024-05-01)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
ανά: Andrea Gastaldi, κ.ά.
Έκδοση: (2021-12-01)

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
ανά: Harrison C. Bergeron, κ.ά.
Έκδοση: (2023-04-01)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus
ανά: Sameer Joshi, κ.ά.
Έκδοση: (2018-05-01)

Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
ανά: Enders Martin, κ.ά.
Έκδοση: (2005-03-01)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
ανά: Anne M Hause, κ.ά.
Έκδοση: (2017-01-01)

Model-based estimates of transmission of respiratory syncytial virus within households
ανά: Ivy K. Kombe, κ.ά.
Έκδοση: (2019-06-01)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
ανά: Anne M Hause, κ.ά.
Έκδοση: (2017-01-01)

Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
ανά: Patricia T. Campbell, κ.ά.
Έκδοση: (2020-11-01)

New Inhibitors of Respiratory Syncytial Virus (RSV) Replication Based on Monoterpene-Substituted Arylcoumarins
ανά: Tatyana M. Khomenko, κ.ά.
Έκδοση: (2023-03-01)

Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations
ανά: Drysdale, S, κ.ά.
Έκδοση: (2020)

Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain
ανά: Sara Jimeno Ruiz, κ.ά.
Έκδοση: (2024-11-01)

Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review
ανά: Anahita Poshtiban, κ.ά.
Έκδοση: (2024-08-01)

Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
ανά: Xiao Li, κ.ά.
Έκδοση: (2024-01-01)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
ανά: Asunci&oacute;n Mej&iacute;as, κ.ά.
Έκδοση: (2008-09-01)

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
ανά: O'Hagan S, κ.ά.
Έκδοση: (2023-09-01)

Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection.
ανά: H K Brand, κ.ά.
Έκδοση: (2015-01-01)